Directors and Officers/Management Liability Insurance
Protect your directors and officers from liabilities related to the operation and management of a business. It provides assurance in the event they are sued in conjunction with the performance of their duties as they relate to the healthcare organization—allowing them to make important business decisions without fear of personal financial loss.
Search
The Doctors Company Announces $7.3 Million Member Dividend
The Doctors Company announced today that it has approved a 2022 premium dividend of approximately $7.3 million, bringing the total of declared dividends to date to more than $446 million.
April 09, 2025, Maryland Medicine
The Resurgence of Medical Liability: How the AMA Supports Its State Medical Associations and Specialty Societies
Medical liability is becoming an advocacy priority for many in organized medicine. One reason is the dramatic rise of “nuclear” jury verdicts (verdicts of at least 10 million dollars). This article includes expert insights from The Doctors Company on this growing issue.
April 12, 2022, Medical Economics
How Doctors Can Minimize Their Chances of Being Sued for Malpractice
Robert E. White, Jr., Chief Operating Officer of The Doctors Company and TDC Group, discusses why thorough, accurate documentation is a doctor’s best defense against malpractice suits.
April 05, 2022, Medical Economics
The Financial Health of Malpractice Insurers
Robert E. White, Jr., Chief Operating Officer of The Doctors Company and TDC Group, notes that malpractice insurance companies have been paying more in settlements than they are collecting in premiums, forcing them to raise premiums.
April 03, 2025, Cardiology Magazine
Critical Insights: Lessons From Delayed Diagnosis, Treatment in the ED
John P. Erwin III, MD, MBA, MACC, Chair, Department of Internal Medicine, Prisma Health Upstate; Clinical Professor, School of Medicine Greenville, University of South Carolina; and Debra A. Davidson, MJ, CPHRM, CPPS, Senior Patient Safety Risk Manager, The Doctors Company, part of TDC Group, review how care and treatment delays contribute to poor patient outcomes and medical malpractice litigation.
Exclusively Endorsed by the American College of Cardiology
The American College of Cardiology exclusively endorses The Doctors Company. ACC members receive unique benefits, including exclusive program discounts and credits.
Member Benefits for the American College of Surgeons
The American College of Surgeons sponsors The Doctors Company. ACS members receive unique benefits, including exclusive program discounts and credits.
The Doctors Company and ProAssurance Announce Early Termination of the Hart-Scott-Rodino Waiting Period
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, and ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical liability, products liability for medical technology and life sciences, and workers’ compensation insurance, announced today that on July 2, 2025, the U.S. Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) with respect to the pending acquisition of ProAssurance by The Doctors Company.
Informed Refusal
Documenting a patient’s refusal of test or treatment options is key to minimizing risk exposure.
